Roy B Simons, Faidra Karkala, Marta M Kukk, Hieab H H Adams, Manfred Kayser, Athina Vidaki
{"title":"Comparative performance evaluation of bisulfite- and enzyme-based DNA conversion methods.","authors":"Roy B Simons, Faidra Karkala, Marta M Kukk, Hieab H H Adams, Manfred Kayser, Athina Vidaki","doi":"10.1186/s13148-025-01855-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Bisulfite conversion (BC) has been the gold standard in DNA methylation profiling for decades. During this chemical process, non-methylated cytosines are converted into uracils, while methylated cytosines remain intact. Despite its popularity, BC has major drawbacks when used for sensitive applications with low-quality and -quantity DNA samples, such as the required large amount of DNA input, the caused DNA fragmentation and loss, and the resulting reduced sequence complexity. Lately, to account for BC-related disadvantages the first commercial enzymatic conversion (EC) kit was launched. While EC follows the same conversion principle as BC it uses two enzymatic steps instead of one chemical step with BC. In this study, we validated and compared the conversion performance of the most widely used BC and EC kits using a multiplex qPCR assay (qBiCo) we recently developed, which provides several indexes: conversion efficiency, converted DNA recovery and fragmentation.</p><p><strong>Results: </strong>Firstly, we implemented and standardized both DNA conversion methods. Secondly, using qBiCo, we performed a developmental validation for both conversion approaches, including testing the following parameters: repeatability, reproducibility, sensitivity and robustness. Regarding conversion efficiency, both methods performed similarly, with the limit of reproducible conversion being 5 ng and 10 ng for BC and EC, respectively. The recovery, however, is structurally overestimated for BC: 2.3 ± 0.7 and 0.7 ± 0.2 for EC. In contrast, degraded DNA input resulted in high fragmentation values after BC and low-medium values for EC (14.4 ± 1.2 and 3.3 ± 0.4, respectively). Finally, we converted 10 ng of 22 genomic DNA samples using both methods. We observed an overestimation of the BC DNA recovery (130%) and a low recovery for EC (40%).</p><p><strong>Conclusions: </strong>Our findings indicate that both DNA conversion methods have strengths and weaknesses. BC shows a high recovery, whereas EC does not cause extensive fragmentation that is characteristic to BC. EC is, therefore, more robust to the analysis of degraded DNA such as forensic-type or cell-free DNA, at least for the genomic DNA inputs tested here. We believe that the low recovery of EC could be improved by further optimizing and automating the bead-based cleanup steps. Overall, our study provides the first independent benchmarking of bisulfite- and enzyme-based conversion kits.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"17 1","pages":"56"},"PeriodicalIF":4.8000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11969950/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Epigenetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13148-025-01855-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Bisulfite conversion (BC) has been the gold standard in DNA methylation profiling for decades. During this chemical process, non-methylated cytosines are converted into uracils, while methylated cytosines remain intact. Despite its popularity, BC has major drawbacks when used for sensitive applications with low-quality and -quantity DNA samples, such as the required large amount of DNA input, the caused DNA fragmentation and loss, and the resulting reduced sequence complexity. Lately, to account for BC-related disadvantages the first commercial enzymatic conversion (EC) kit was launched. While EC follows the same conversion principle as BC it uses two enzymatic steps instead of one chemical step with BC. In this study, we validated and compared the conversion performance of the most widely used BC and EC kits using a multiplex qPCR assay (qBiCo) we recently developed, which provides several indexes: conversion efficiency, converted DNA recovery and fragmentation.
Results: Firstly, we implemented and standardized both DNA conversion methods. Secondly, using qBiCo, we performed a developmental validation for both conversion approaches, including testing the following parameters: repeatability, reproducibility, sensitivity and robustness. Regarding conversion efficiency, both methods performed similarly, with the limit of reproducible conversion being 5 ng and 10 ng for BC and EC, respectively. The recovery, however, is structurally overestimated for BC: 2.3 ± 0.7 and 0.7 ± 0.2 for EC. In contrast, degraded DNA input resulted in high fragmentation values after BC and low-medium values for EC (14.4 ± 1.2 and 3.3 ± 0.4, respectively). Finally, we converted 10 ng of 22 genomic DNA samples using both methods. We observed an overestimation of the BC DNA recovery (130%) and a low recovery for EC (40%).
Conclusions: Our findings indicate that both DNA conversion methods have strengths and weaknesses. BC shows a high recovery, whereas EC does not cause extensive fragmentation that is characteristic to BC. EC is, therefore, more robust to the analysis of degraded DNA such as forensic-type or cell-free DNA, at least for the genomic DNA inputs tested here. We believe that the low recovery of EC could be improved by further optimizing and automating the bead-based cleanup steps. Overall, our study provides the first independent benchmarking of bisulfite- and enzyme-based conversion kits.
背景:几十年来,亚硫酸氢盐转化(BC)一直是 DNA 甲基化分析的黄金标准。在这一化学过程中,非甲基化胞嘧啶转化为尿嘧啶,而甲基化胞嘧啶则保持不变。尽管 BC 很受欢迎,但当用于低质量和低数量 DNA 样本的敏感应用时,它也有很大的缺点,如需要输入大量 DNA、造成 DNA 断裂和丢失,以及导致序列复杂性降低。最近,为了解决与 BC 相关的缺点,推出了第一款商业酶转换(EC)试剂盒。虽然 EC 与 BC 的转换原理相同,但它使用了两个酶步骤,而不是 BC 的一个化学步骤。在本研究中,我们使用最近开发的多重 qPCR 检测(qBiCo)验证并比较了最广泛使用的 BC 和 EC 试剂盒的转换性能,该检测提供了几个指标:转换效率、转换后 DNA 的回收率和破碎率:结果:首先,我们实现了两种 DNA 转换方法的标准化。其次,我们利用 qBiCo 对两种转化方法进行了开发验证,包括测试以下参数:重复性、再现性、灵敏度和稳健性。在转化效率方面,两种方法表现相似,BC 和 EC 的可重复转化极限分别为 5 毫微克和 10 毫微克。不过,BC 的回收率在结构上被高估了:2.3 ± 0.7,EC 为 0.7 ± 0.2。相比之下,降解的 DNA 输入在 BC 后会产生较高的片段值,而在 EC 后会产生中等偏低的片段值(分别为 14.4 ± 1.2 和 3.3 ± 0.4)。最后,我们用这两种方法对 22 个基因组 DNA 样本中的 10 纳克进行了转换。我们观察到 BC DNA 的回收率被高估了(130%),而 EC 的回收率较低(40%):我们的研究结果表明,两种 DNA 转换方法各有优缺点。BC法的回收率高,而EC法不会造成BC法特有的大面积片段化。因此,至少对本文测试的基因组 DNA 输入而言,EC 更适合分析降解的 DNA,如法医类型或无细胞 DNA。我们认为,EC 的低回收率可以通过进一步优化和自动化基于微珠的净化步骤得到改善。总之,我们的研究首次对基于亚硫酸氢盐和酶的转化试剂盒进行了独立的基准测试。
期刊介绍:
Clinical Epigenetics, the official journal of the Clinical Epigenetics Society, is an open access, peer-reviewed journal that encompasses all aspects of epigenetic principles and mechanisms in relation to human disease, diagnosis and therapy. Clinical trials and research in disease model organisms are particularly welcome.